Original Article

Young Adult Males’ Perspectives of Male Hormonal Contraception

Authors: Megan R. Sax, MD, Emily G. Hurley, MD, Rocco A. Rossi, MD, MA, Suruchi Thakore,MD, Abhinav Hasija, PhD, Julie Sroga-Rios, MD

Abstract

Objective: To evaluate the willingness of young adult males to use male hormonal contraception and to determine the most desirable formulation.

Methods: An institutional review board–approved survey measuring the willingness to use MHC was dispersed to two distinct populations: University of Cincinnati postgraduate programs and Cincinnati Health Department clinics. Questions on the survey allowed for the collection of demographic characteristics, as well as the preferred method of MHC, and concerns regarding potential adverse effects. This survey was directed at young adult males; therefore, only male participants who were 18 to 35 years old were included for analysis. Results were reported as frequencies in each group and χ2 analyses were performed to compare groups, with a P < 0.05 considered significant.

Results: Of 162 total survey participants, 45% would use MHC, whereas 30.9% were unsure and 23.5% would not use MHC. Overall, the University of Cincinnati survey population was more likely to be interested in using MHC than the Cincinnati Health Department population (P < 0.05). In both populations, most were interested in using the injectable form. Cited concerns deterring participants from using MHC were different between these two populations, with University of Cincinnati participants more frequently expressing concerns about possible failure of the contraceptive method, whereas Cincinnati Health Department participants had concerns about potential adverse effects (P < 0.001).

Conclusions: There is significant interest among young adult males in using various forms of MHC, especially in injectable form. Differences in views of MHC were seen in two distinct male populations. Specifically, males who achieved a higher level of education, were employed, or in a relationship were found to more frequently be willing to use MHC. With further research and funding, MHC may serve as a significant way to decrease unintended pregnancies in the future.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Nieschlag E. Clinical trials in male hormonal contraception. Contraception 2010;82:457–470. 2. Daniels K, Daugherty J, Jones J. Current contraceptive status among women aged 15-44: United States, 2011-2013. NCHS Data Brief 2014;(173):1–8. 3. Ayoub R, Page ST, Swerdloff RS, et al. Comparison of the single dose pharmacokinetics, pharmacodynamics, and safety of two novel oral formulations of dimethandrolone undecanoate (DMAU): a potential oral, male contraceptive. Andrology 2016;5:278–285. 4. Behre HM, Zitzmann M, Anderson RA, et al. Efficacy and safety of an injectable combination hormonal contraceptive for men. J Clin Endocrinol Metab 2016;101:4779–4788. 5. Roth MY, Shih G, Ilani N, et al. Acceptability of a transdermal gel-based male hormonal contraceptive in a randomized controlled trial. Contraception 2014:90:407–412. 6. Glasier A, Anakwe R, Everington D, et al. Would women trust their partners to use a male pill? Hum Reprod 2000;15:646–649. 7. Marcell AV, Plowden K, Bowman SM. Exploring older adolescents’ and young adults’ attitudes regarding MHC: applications for clinical practice. Hum Reprod 2005;20:3078–3084. 8. Heinemann K, Saad F, Wiesemes M, et al. Attitudes toward male fertility control: results of a multinational survey on four continents. Hum Reprod 2005;20:549–556. 9. Glasier A. Acceptability of contraception for men: a review. Contraception 2010;82:453–456. 10. US Census Bureau. Age and sex composition: 2010. 2010 Census Briefs. https://www.census.gov/prod/cen2010/briefs/c2010br-03.pdf. Published May 2011. Accessed November 25, 2020. 11. Guttmacher Institute. Contraceptive use in the United States: who needs contraceptives? https://www.guttmacher.org/fact-sheet/contraceptive-useunited-states. Published 2016. Accessed November 25, 2020. 12. Mestad R, Secura G, Allsworth JE, et al. Acceptance of long-acting reversible contraceptive methods by adolescent participants in the contraceptive CHOICE project. Contraception 2011;84:493–498. 13. Finer LB, Zolna MR. Declines in unintended pregnancy in the United States, 2008-2011. N Engl J Med 2016;374:843–852.